Biotech Analyst Schimmer along with Ricky Safer, Founder & CEO of PSC Partners, discuss new drugs in development for treating patients with Primary Sclerosing Cholangitis on an Analyst/Industry conference call to be held on March 1 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MIRM:
- Mirum Pharmaceuticals publishes data from Livmarli analysis
- Mirum Pharmaceuticals price target raised to $69 from $64 at JMP Securities
- Mirum Pharmaceuticals reports Q4 revenue $69.554M, consensus $67.91M
- Is MIRM a Buy, Before Earnings?
- Mirum Pharmaceuticals management to meet with Cantor Fitzgerald
